Multidrug Resistance Protein 4 (MRP4/ABCC4) Protects Cells from the Toxic Effects of Halobenzoquinones

被引:12
|
作者
Li, Jinhua [1 ,2 ]
Bauer, Madlen [1 ]
Moe, Birget [1 ,3 ]
Leslie, Elaine M. [1 ,4 ]
Li, Xing-Fang [1 ]
机构
[1] Univ Alberta, Fac Med & Dent, Dept Lab Med & Pathol, Div Analyt & Environm Toxicol, Edmonton, AB T6G 2G3, Canada
[2] Jilin Univ, Sch Publ Hlth, Changchun 130021, Jilin, Peoples R China
[3] Univ Calgary, Fac Med, Dept Physiol & Pharmacol, Alberta Ctr Toxicol, Calgary, AB T2N 4N1, Canada
[4] Univ Alberta, Fac Med & Dent, Dept Physiol, Edmonton, AB T6G 2H7, Canada
基金
加拿大健康研究院; 加拿大自然科学与工程研究理事会;
关键词
DISINFECTION BY-PRODUCTS; DRINKING-WATER DISINFECTION; OXIDATIVE STRESS; BROMO-BENZOQUINONES; REDUCED GLUTATHIONE; THIOL REACTIVITY; ELIMINATION; TRANSPORTER; COTRANSPORT; ACIDS;
D O I
10.1021/acs.chemrestox.7b00156
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Halobenzoquinones (HBQs) are frequently detected disinfection byproducts (DBPs) in treated water. Recent studies have demonstrated that HBQs are highly cytotoxic and capable of inducing the generation of reactive oxygen species (ROS) and depleting cellular glutathione (GSH). Multidrug resistance proteins (MRPs/ABCCs) are known to play a critical role in the elimination of numerous drugs, carcinogens, toxicants, and their conjugated metabolites. In general, little is known about the roles of transporters in DBP toxicity. Here, we hypothesize that MRPs may play roles in the detoxication of HBQs. To test this hypothesis, we used human embryonic kidney 293 (HEK293) cells stably expressing MRPs (MRP1, 3, 4, and 5) and HEK293 cells with empty vector (HEK-V) to examine the comparative cytotoxicity of four HBQs: 2,6-dichloro-1,4-benzoquinone (2,6-DCBQ), 2,6-dibromo-1,4-benzoquinone (2,6-DBBQ), 2,6-dichloro-3-methyl-1,4-benzoquinone (DCMBQ), and 2,3,6-trichloro-1,4-benzoquinone (TriCBQ). The cytotoxicity (IC50) of the four HBQs in HEK-MRP1, -MRP3, -MRP4, and -MRP5 cells and the control HEK-V cells clearly showed that MRP4 had the most significant effect on reducing the toxicity of the four HBQs. To further support MRP4-mediated detoxication of HBQs, we examined the HBQ-induced ROS levels in HEK-MRP4 and HEK-V cells. ROS levels were significantly reduced in HEK-MRP4 cells compared with HEK-V cells after HBQ treatment. Furthermore, it was found that MRP4-mediated detoxication of the HBQs was GSH dependent, as the cytotoxicity of the HBQs was increased in GSH-depleted HEK-MRP4 cells in comparison to HEK-MRP4 cells. The GSH-dependent protection of cells from HBQs supports the possibility of HBQ-GSH conjugate efflux by MRP4. This study demonstrates a role for MRP4 in cellular protection against HBQ DBP-induced toxicity and oxidative stress.
引用
收藏
页码:1815 / 1822
页数:8
相关论文
共 50 条
  • [21] Influence of protein interactions and PKC activity on MRP4 (ABCC4)
    Broederdorf, S.
    Schaletzki, Y.
    Kromrey, M. -L.
    Kroemer, H. K.
    Siegmund, W.
    Jedlitschky, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S13 - S13
  • [22] Regulation of the ABC transporter MRP4 (ABCC4) by protein interactions
    Kromrey, M. -L.
    Schaletzki, Y.
    Zang, S.
    Broederdorf, S.
    Kroemer, H. K.
    Jedlitschkv, G.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 56 - 56
  • [23] Bile salt and glutathione coefflux mediated by multidrug resistance protein MRP4 (ABCC4), a basolateral transporter of the hepatocyte
    Rius, M
    Nies, AT
    Hofmann, AF
    Keppler, D
    Bile Acid Biology and Its Therapeutic Implications, 2005, 141 : 101 - 106
  • [24] ATP-dependent transport of Leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4)
    Rius, Maria
    Hummel-Eisenbeiss, Johanna
    Keppler, Dietrich
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 324 (01): : 86 - 94
  • [25] Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness
    Sahores, A.
    Carozzo, A.
    May, M.
    Gomez, N.
    Di Siervi, N.
    De Sousa Serro, M.
    Yaneff, A.
    Rodriguez-Gonzalez, A.
    Abba, M.
    Shayo, C.
    Davio, C.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [26] Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness
    A. Sahores
    A. Carozzo
    M. May
    N. Gómez
    N. Di Siervi
    M. De Sousa Serro
    A. Yaneff
    A. Rodríguez-González
    M. Abba
    C. Shayo
    C. Davio
    Scientific Reports, 10
  • [27] Multidrug resistance protein 4 (MRP4/ABCC4) and its functional. comparison with MRP2/ABCC2 for transport of renal organic anions
    Russel, FGM
    Smeets, PHE
    Huls, M
    Mulders, ACM
    Wouterse, AC
    Masereeuw, R
    van Aubel, RAMH
    FASEB JOURNAL, 2003, 17 (04): : A478 - A478
  • [28] Unimpaired immune functions in the absence of Mrp4 (Abcc4)
    van de Ven, Rieneke
    de Groot, Jan
    Reurs, Anneke W.
    Wijnands, Pepijn G. J. T. B.
    van de Wetering, Koen
    Schuetz, John D.
    de Gruijl, Tanja D.
    Scheper, Rik J.
    Scheffer, George L.
    IMMUNOLOGY LETTERS, 2009, 124 (02) : 81 - 87
  • [29] Missense mutations in the multidrug resistance-associated protein 2 (MRP2/ABCC2) and 4 (MRP4/ABCC4):: impact on protein expression and drug tansport
    Lang, T.
    Janke, D.
    Mehralivand, S.
    Shamsinejad, M.
    Strand, D.
    Goedtel-Armbrust, U.
    Habermeier, A.
    Gradhand, U.
    Fischer, C.
    Toliat, M. R.
    Fritz, P.
    Zanger, U. M.
    Schwab, M.
    Fromm, M. F.
    Nuernberg, P.
    Closs, E. I.
    Wojnowski, L.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 377 - 377
  • [30] Identification of protein partners interacting with the transporter MRP4/ABCC4 in platelets
    Schaletzki, Yvonne
    Broederdorf, Susanne
    Kromrey, Marie-Luise
    Kroemer, Heyo K.
    Jedlitschky, Gabriele
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2014, 387 : S82 - S82